nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—Microtubule Inhibition—Docetaxel—lung cancer	0.231	1	CiPCiCtD
Paclitaxel—Docetaxel—lung cancer	0.219	1	CrCtD
Paclitaxel—kidney cancer—lung cancer	0.124	1	CtDrD
Paclitaxel—Cabazitaxel—Docetaxel—lung cancer	0.124	1	CrCrCtD
Paclitaxel—ABCG2—lung cancer	0.035	0.706	CbGaD
Paclitaxel—ABCB1—lung cancer	0.0146	0.294	CbGaD
Paclitaxel—MAP4—Docetaxel—lung cancer	0.00862	0.0488	CbGbCtD
Paclitaxel—MAP2—Docetaxel—lung cancer	0.00623	0.0353	CbGbCtD
Paclitaxel—MAPT—Docetaxel—lung cancer	0.00623	0.0353	CbGbCtD
Paclitaxel—TUBB2A—Vinorelbine—lung cancer	0.0056	0.0317	CbGbCtD
Paclitaxel—TUBB8—Vinorelbine—lung cancer	0.0056	0.0317	CbGbCtD
Paclitaxel—TUBB6—Vinorelbine—lung cancer	0.0056	0.0317	CbGbCtD
Paclitaxel—TUBB3—Vinorelbine—lung cancer	0.0056	0.0317	CbGbCtD
Paclitaxel—TUBB4A—Vinorelbine—lung cancer	0.0056	0.0317	CbGbCtD
Paclitaxel—TUBB2B—Vinorelbine—lung cancer	0.0056	0.0317	CbGbCtD
Paclitaxel—BCL2—Docetaxel—lung cancer	0.00495	0.028	CbGbCtD
Paclitaxel—TUBB—Vinorelbine—lung cancer	0.00468	0.0265	CbGbCtD
Paclitaxel—TUBB4B—Vinorelbine—lung cancer	0.00468	0.0265	CbGbCtD
Paclitaxel—TUBB1—Vinorelbine—lung cancer	0.00468	0.0265	CbGbCtD
Paclitaxel—NR1I2—Erlotinib—lung cancer	0.00391	0.0221	CbGbCtD
Paclitaxel—TUBB6—Vinblastine—lung cancer	0.00345	0.0195	CbGbCtD
Paclitaxel—TUBB2A—Vinblastine—lung cancer	0.00345	0.0195	CbGbCtD
Paclitaxel—TUBB8—Vinblastine—lung cancer	0.00345	0.0195	CbGbCtD
Paclitaxel—TUBB4A—Vinblastine—lung cancer	0.00345	0.0195	CbGbCtD
Paclitaxel—TUBB2B—Vinblastine—lung cancer	0.00345	0.0195	CbGbCtD
Paclitaxel—TUBB3—Vinblastine—lung cancer	0.00345	0.0195	CbGbCtD
Paclitaxel—TUBB—Vinblastine—lung cancer	0.00288	0.0163	CbGbCtD
Paclitaxel—TUBB1—Vinblastine—lung cancer	0.00288	0.0163	CbGbCtD
Paclitaxel—TUBB4B—Vinblastine—lung cancer	0.00288	0.0163	CbGbCtD
Paclitaxel—TUBB4A—Docetaxel—lung cancer	0.00284	0.0161	CbGbCtD
Paclitaxel—TUBB2B—Docetaxel—lung cancer	0.00284	0.0161	CbGbCtD
Paclitaxel—TUBB3—Docetaxel—lung cancer	0.00284	0.0161	CbGbCtD
Paclitaxel—TUBB2A—Docetaxel—lung cancer	0.00284	0.0161	CbGbCtD
Paclitaxel—TUBB6—Docetaxel—lung cancer	0.00284	0.0161	CbGbCtD
Paclitaxel—TUBB8—Docetaxel—lung cancer	0.00284	0.0161	CbGbCtD
Paclitaxel—ABCC10—Gemcitabine—lung cancer	0.00278	0.0158	CbGbCtD
Paclitaxel—NR1I2—Docetaxel—lung cancer	0.00259	0.0147	CbGbCtD
Paclitaxel—TUBB—Docetaxel—lung cancer	0.00238	0.0135	CbGbCtD
Paclitaxel—TUBB4B—Docetaxel—lung cancer	0.00238	0.0135	CbGbCtD
Paclitaxel—TUBB1—Docetaxel—lung cancer	0.00238	0.0135	CbGbCtD
Paclitaxel—ABCC10—Etoposide—lung cancer	0.00199	0.0112	CbGbCtD
Paclitaxel—ABCC10—Docetaxel—lung cancer	0.00182	0.0103	CbGbCtD
Paclitaxel—CYP1B1—Erlotinib—lung cancer	0.00149	0.00845	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—lung cancer	0.00135	0.00767	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—lung cancer	0.00131	0.00743	CbGbCtD
Paclitaxel—ABCG2—Topotecan—lung cancer	0.00131	0.00743	CbGbCtD
Paclitaxel—ABCG2—Gefitinib—lung cancer	0.0012	0.00679	CbGbCtD
Paclitaxel—ABCB11—Vinblastine—lung cancer	0.0012	0.00678	CbGbCtD
Paclitaxel—ABCG2—Teniposide—lung cancer	0.00116	0.00659	CbGbCtD
Paclitaxel—SLCO1B3—Docetaxel—lung cancer	0.00101	0.00575	CbGbCtD
Paclitaxel—CYP1B1—Docetaxel—lung cancer	0.000987	0.00559	CbGbCtD
Paclitaxel—ABCC1—Irinotecan—lung cancer	0.000957	0.00542	CbGbCtD
Paclitaxel—ABCC1—Vinblastine—lung cancer	0.000851	0.00482	CbGbCtD
Paclitaxel—ABCC1—Etoposide—lung cancer	0.000767	0.00434	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—lung cancer	0.000736	0.00417	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—lung cancer	0.000736	0.00417	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—lung cancer	0.000733	0.00415	CbGbCtD
Paclitaxel—ABCG2—Erlotinib—lung cancer	0.000709	0.00402	CbGbCtD
Paclitaxel—ABCC2—Irinotecan—lung cancer	0.000708	0.00401	CbGbCtD
Paclitaxel—ABCC1—Docetaxel—lung cancer	0.000701	0.00397	CbGbCtD
Paclitaxel—CYP3A5—Gefitinib—lung cancer	0.000664	0.00376	CbGbCtD
Paclitaxel—CYP3A5—Teniposide—lung cancer	0.000644	0.00365	CbGbCtD
Paclitaxel—ABCG2—Irinotecan—lung cancer	0.00064	0.00363	CbGbCtD
Paclitaxel—ABCC2—Vinblastine—lung cancer	0.00063	0.00357	CbGbCtD
Paclitaxel—ABCC2—Cisplatin—lung cancer	0.000577	0.00327	CbGbCtD
Paclitaxel—ABCC2—Etoposide—lung cancer	0.000567	0.00321	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—lung cancer	0.000523	0.00296	CbGbCtD
Paclitaxel—ABCG2—Cisplatin—lung cancer	0.000522	0.00296	CbGbCtD
Paclitaxel—ABCC2—Docetaxel—lung cancer	0.000519	0.00294	CbGbCtD
Paclitaxel—ABCG2—Etoposide—lung cancer	0.000513	0.00291	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—lung cancer	0.000506	0.00287	CbGbCtD
Paclitaxel—CYP3A7—Irinotecan—lung cancer	0.000473	0.00268	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.000473	0.00268	CbGbCtD
Paclitaxel—ABCB1—Topotecan—lung cancer	0.000473	0.00268	CbGbCtD
Paclitaxel—ABCG2—Docetaxel—lung cancer	0.000469	0.00266	CbGbCtD
Paclitaxel—CYP2C9—Gefitinib—lung cancer	0.000446	0.00252	CbGbCtD
Paclitaxel—ABCB1—Gefitinib—lung cancer	0.000432	0.00245	CbGbCtD
Paclitaxel—CYP2C9—Teniposide—lung cancer	0.000432	0.00245	CbGbCtD
Paclitaxel—MAP4—mammary gland—lung cancer	0.000417	0.0436	CbGeAlD
Paclitaxel—CYP3A5—Crizotinib—lung cancer	0.000407	0.00231	CbGbCtD
Paclitaxel—CYP3A5—Erlotinib—lung cancer	0.000393	0.00223	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—lung cancer	0.000387	0.00219	CbGbCtD
Paclitaxel—CYP2C8—Erlotinib—lung cancer	0.000378	0.00214	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—lung cancer	0.000375	0.00212	CbGbCtD
Paclitaxel—CYP3A5—Irinotecan—lung cancer	0.000355	0.00201	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—lung cancer	0.00035	0.00198	CbGbCtD
Paclitaxel—CYP3A7—Docetaxel—lung cancer	0.000347	0.00196	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.000347	0.00196	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—lung cancer	0.000339	0.00192	CbGbCtD
Paclitaxel—ABCB1—Vinorelbine—lung cancer	0.000333	0.00189	CbGbCtD
Paclitaxel—CYP3A5—Etoposide—lung cancer	0.000284	0.00161	CbGbCtD
Paclitaxel—CYP3A4—Topotecan—lung cancer	0.000283	0.0016	CbGbCtD
Paclitaxel—MAP4—respiratory system—lung cancer	0.000278	0.029	CbGeAlD
Paclitaxel—TUBB3—respiratory system—lung cancer	0.000278	0.029	CbGeAlD
Paclitaxel—CYP2C8—Etoposide—lung cancer	0.000273	0.00155	CbGbCtD
Paclitaxel—ABCB1—Crizotinib—lung cancer	0.000265	0.0015	CbGbCtD
Paclitaxel—CYP3A5—Docetaxel—lung cancer	0.00026	0.00147	CbGbCtD
Paclitaxel—CYP3A4—Gefitinib—lung cancer	0.000259	0.00147	CbGbCtD
Paclitaxel—ABCB1—Gemcitabine—lung cancer	0.000259	0.00147	CbGbCtD
Paclitaxel—ABCB1—Erlotinib—lung cancer	0.000256	0.00145	CbGbCtD
Paclitaxel—BCL2—respiratory system—lung cancer	0.000252	0.0264	CbGeAlD
Paclitaxel—CYP3A4—Teniposide—lung cancer	0.000251	0.00142	CbGbCtD
Paclitaxel—ABCB1—Irinotecan—lung cancer	0.000231	0.00131	CbGbCtD
Paclitaxel—TUBB6—mammary gland—lung cancer	0.000228	0.0238	CbGeAlD
Paclitaxel—MAP2—respiratory system—lung cancer	0.000219	0.0229	CbGeAlD
Paclitaxel—BCL2—Irinotecan—Topotecan—lung cancer	0.000216	0.327	CbGdCrCtD
Paclitaxel—BCL2—epithelium—lung cancer	0.000211	0.0221	CbGeAlD
Paclitaxel—ABCB1—Vinblastine—lung cancer	0.000205	0.00116	CbGbCtD
Paclitaxel—CYP3A4—Vinorelbine—lung cancer	0.0002	0.00113	CbGbCtD
Paclitaxel—TUBB4B—mammary gland—lung cancer	0.000198	0.0207	CbGeAlD
Paclitaxel—CYP2C9—Cisplatin—lung cancer	0.000194	0.0011	CbGbCtD
Paclitaxel—ABCB1—Cisplatin—lung cancer	0.000188	0.00107	CbGbCtD
Paclitaxel—Docetaxel—EGFR—lung cancer	0.000188	0.302	CrCbGaD
Paclitaxel—ABCB1—Etoposide—lung cancer	0.000185	0.00105	CbGbCtD
Paclitaxel—MAP2—bronchus—lung cancer	0.00018	0.0188	CbGeAlD
Paclitaxel—Cabazitaxel—ABCG2—lung cancer	0.00017	0.273	CrCbGaD
Paclitaxel—ABCB1—Docetaxel—lung cancer	0.000169	0.000959	CbGbCtD
Paclitaxel—TUBB4A—respiratory system—lung cancer	0.000169	0.0177	CbGeAlD
Paclitaxel—TUBB2B—respiratory system—lung cancer	0.000163	0.0171	CbGeAlD
Paclitaxel—MAP2—trachea—lung cancer	0.000162	0.0169	CbGeAlD
Paclitaxel—TUBB1—bone marrow—lung cancer	0.000159	0.0166	CbGeAlD
Paclitaxel—CYP3A4—Crizotinib—lung cancer	0.000159	0.0009	CbGbCtD
Paclitaxel—CYP1B1—mammary gland—lung cancer	0.000157	0.0164	CbGeAlD
Paclitaxel—TUBB2A—respiratory system—lung cancer	0.000154	0.0161	CbGeAlD
Paclitaxel—CYP3A4—Erlotinib—lung cancer	0.000153	0.000868	CbGbCtD
Paclitaxel—MAP2—cardiac atrium—lung cancer	0.000152	0.0159	CbGeAlD
Paclitaxel—TUBB6—respiratory system—lung cancer	0.000152	0.0159	CbGeAlD
Paclitaxel—BCL2—bone marrow—lung cancer	0.000148	0.0155	CbGeAlD
Paclitaxel—TUBB3—lung—lung cancer	0.000147	0.0154	CbGeAlD
Paclitaxel—MAP4—lung—lung cancer	0.000147	0.0154	CbGeAlD
Paclitaxel—TUBB3—Afatinib—Gefitinib—lung cancer	0.000145	0.22	CbGdCrCtD
Paclitaxel—CYP3A4—Irinotecan—lung cancer	0.000138	0.000784	CbGbCtD
Paclitaxel—Docetaxel—ABCG2—lung cancer	0.000137	0.22	CrCbGaD
Paclitaxel—TUBB2B—bronchus—lung cancer	0.000134	0.0141	CbGeAlD
Paclitaxel—BCL2—lung—lung cancer	0.000134	0.014	CbGeAlD
Paclitaxel—TUBB4B—respiratory system—lung cancer	0.000132	0.0138	CbGeAlD
Paclitaxel—SLCO1B3—lung—lung cancer	0.000129	0.0135	CbGeAlD
Paclitaxel—MAPT—lymph node—lung cancer	0.000128	0.0134	CbGeAlD
Paclitaxel—TUBB—bronchus—lung cancer	0.000127	0.0133	CbGeAlD
Paclitaxel—TUBB6—epithelium—lung cancer	0.000127	0.0133	CbGeAlD
Paclitaxel—TUBB2A—bronchus—lung cancer	0.000127	0.0132	CbGeAlD
Paclitaxel—ABCB1—Doxorubicin—lung cancer	0.000126	0.000715	CbGbCtD
Paclitaxel—TUBB6—bronchus—lung cancer	0.000125	0.0131	CbGeAlD
Paclitaxel—CYP3A4—Vinblastine—lung cancer	0.000123	0.000697	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—lung cancer	0.000122	0.000692	CbGbCtD
Paclitaxel—TUBB2B—trachea—lung cancer	0.000121	0.0126	CbGeAlD
Paclitaxel—CYP2C8—mammary gland—lung cancer	0.00012	0.0125	CbGeAlD
Paclitaxel—MAP2—lung—lung cancer	0.000116	0.0121	CbGeAlD
Paclitaxel—TUBB—trachea—lung cancer	0.000114	0.0119	CbGeAlD
Paclitaxel—TUBB2A—trachea—lung cancer	0.000114	0.0119	CbGeAlD
Paclitaxel—TUBB2B—cardiac atrium—lung cancer	0.000113	0.0119	CbGeAlD
Paclitaxel—TUBB6—trachea—lung cancer	0.000112	0.0117	CbGeAlD
Paclitaxel—CYP3A4—Etoposide—lung cancer	0.000111	0.000628	CbGbCtD
Paclitaxel—ABCC10—bronchus—lung cancer	0.000109	0.0114	CbGeAlD
Paclitaxel—TUBB4B—bronchus—lung cancer	0.000108	0.0113	CbGeAlD
Paclitaxel—TUBB—cardiac atrium—lung cancer	0.000107	0.0112	CbGeAlD
Paclitaxel—TUBB2A—cardiac atrium—lung cancer	0.000107	0.0112	CbGeAlD
Paclitaxel—CYP2C9—mammary gland—lung cancer	0.000107	0.0111	CbGeAlD
Paclitaxel—TUBB6—cardiac atrium—lung cancer	0.000105	0.011	CbGeAlD
Paclitaxel—CYP1B1—respiratory system—lung cancer	0.000104	0.0109	CbGeAlD
Paclitaxel—CYP3A4—Docetaxel—lung cancer	0.000101	0.000574	CbGbCtD
Paclitaxel—MAP4—lymph node—lung cancer	0.000101	0.0105	CbGeAlD
Paclitaxel—ABCC10—trachea—lung cancer	9.81e-05	0.0103	CbGeAlD
Paclitaxel—TUBB4B—trachea—lung cancer	9.74e-05	0.0102	CbGeAlD
Paclitaxel—ABCC10—cardiac atrium—lung cancer	9.22e-05	0.00964	CbGeAlD
Paclitaxel—BCL2—lymph node—lung cancer	9.17e-05	0.00959	CbGeAlD
Paclitaxel—TUBB4B—cardiac atrium—lung cancer	9.15e-05	0.00957	CbGeAlD
Paclitaxel—TUBB—bone marrow—lung cancer	9.06e-05	0.00947	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—lung cancer	9.01e-05	0.00942	CbGeAlD
Paclitaxel—TUBB4A—lung—lung cancer	8.97e-05	0.00939	CbGeAlD
Paclitaxel—TUBB4B—Afatinib—Gefitinib—lung cancer	8.95e-05	0.136	CbGdCrCtD
Paclitaxel—TUBB6—bone marrow—lung cancer	8.89e-05	0.0093	CbGeAlD
Paclitaxel—TUBB2B—lung—lung cancer	8.67e-05	0.00907	CbGeAlD
Paclitaxel—TUBB—lung—lung cancer	8.21e-05	0.00858	CbGeAlD
Paclitaxel—TUBB2A—lung—lung cancer	8.16e-05	0.00854	CbGeAlD
Paclitaxel—TUBB6—lung—lung cancer	8.05e-05	0.00842	CbGeAlD
Paclitaxel—MAP2—lymph node—lung cancer	7.94e-05	0.00831	CbGeAlD
Paclitaxel—ABCC10—bone marrow—lung cancer	7.78e-05	0.00814	CbGeAlD
Paclitaxel—ABCC1—bronchus—lung cancer	7.73e-05	0.00808	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—lung cancer	7.73e-05	0.00808	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—lung cancer	7.56e-05	0.000428	CbGbCtD
Paclitaxel—CYP3A5—respiratory system—lung cancer	7.22e-05	0.00755	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—lung cancer	7.07e-05	0.114	CrCbGaD
Paclitaxel—ABCC10—lung—lung cancer	7.05e-05	0.00737	CbGeAlD
Paclitaxel—TUBB4B—lung—lung cancer	7e-05	0.00732	CbGeAlD
Paclitaxel—ABCC1—trachea—lung cancer	6.94e-05	0.00726	CbGeAlD
Paclitaxel—TUBB6—Erlotinib—Gefitinib—lung cancer	6.82e-05	0.103	CbGdCrCtD
Paclitaxel—ABCC1—cardiac atrium—lung cancer	6.52e-05	0.00682	CbGeAlD
Paclitaxel—TUBB4A—lymph node—lung cancer	6.14e-05	0.00642	CbGeAlD
Paclitaxel—TUBB2B—lymph node—lung cancer	5.93e-05	0.0062	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—lung cancer	5.71e-05	0.0917	CrCbGaD
Paclitaxel—TUBB6—Zalcitabine—Gemcitabine—lung cancer	5.62e-05	0.0851	CbGdCrCtD
Paclitaxel—TUBB—lymph node—lung cancer	5.61e-05	0.00587	CbGeAlD
Paclitaxel—TUBB2A—lymph node—lung cancer	5.58e-05	0.00584	CbGeAlD
Paclitaxel—CYP1B1—lung—lung cancer	5.54e-05	0.0058	CbGeAlD
Paclitaxel—TUBB6—lymph node—lung cancer	5.51e-05	0.00576	CbGeAlD
Paclitaxel—ABCC1—lung—lung cancer	4.99e-05	0.00522	CbGeAlD
Paclitaxel—ABCC10—lymph node—lung cancer	4.82e-05	0.00504	CbGeAlD
Paclitaxel—TUBB4B—lymph node—lung cancer	4.79e-05	0.00501	CbGeAlD
Paclitaxel—ABCG2—bone marrow—lung cancer	4.56e-05	0.00477	CbGeAlD
Paclitaxel—TUBB6—Afatinib—Gefitinib—lung cancer	4.46e-05	0.0676	CbGdCrCtD
Paclitaxel—ABCG2—lung—lung cancer	4.13e-05	0.00432	CbGeAlD
Paclitaxel—CYP19A1—lymph node—lung cancer	4.06e-05	0.00424	CbGeAlD
Paclitaxel—ABCC2—lymph node—lung cancer	3.87e-05	0.00405	CbGeAlD
Paclitaxel—ABCB1—respiratory system—lung cancer	3.83e-05	0.00401	CbGeAlD
Paclitaxel—CYP3A5—lung—lung cancer	3.83e-05	0.00401	CbGeAlD
Paclitaxel—CYP1B1—lymph node—lung cancer	3.79e-05	0.00397	CbGeAlD
Paclitaxel—ABCC1—lymph node—lung cancer	3.41e-05	0.00357	CbGeAlD
Paclitaxel—ABCB1—epithelium—lung cancer	3.2e-05	0.00335	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Gemcitabine—lung cancer	2.86e-05	0.0433	CbGdCrCtD
Paclitaxel—ABCB1—trachea—lung cancer	2.83e-05	0.00296	CbGeAlD
Paclitaxel—ABCG2—lymph node—lung cancer	2.82e-05	0.00295	CbGeAlD
Paclitaxel—ABCB1—bone marrow—lung cancer	2.25e-05	0.00235	CbGeAlD
Paclitaxel—ABCB1—lung—lung cancer	2.04e-05	0.00213	CbGeAlD
Paclitaxel—ABCB1—lymph node—lung cancer	1.39e-05	0.00146	CbGeAlD
Paclitaxel—TUBB6—Azacitidine—Gemcitabine—lung cancer	1.18e-05	0.0179	CbGdCrCtD
Paclitaxel—Dysuria—Doxorubicin—lung cancer	5.49e-06	0.000133	CcSEcCtD
Paclitaxel—Dry mouth—Docetaxel—lung cancer	5.46e-06	0.000132	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—lung cancer	5.46e-06	0.000132	CcSEcCtD
Paclitaxel—Haemoglobin—Methotrexate—lung cancer	5.46e-06	0.000132	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—lung cancer	5.43e-06	0.000131	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—lung cancer	5.43e-06	0.000131	CcSEcCtD
Paclitaxel—Asthenia—Gemcitabine—lung cancer	5.41e-06	0.000131	CcSEcCtD
Paclitaxel—Confusional state—Docetaxel—lung cancer	5.4e-06	0.000131	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—lung cancer	5.39e-06	0.00013	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—lung cancer	5.36e-06	0.00013	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Doxorubicin—lung cancer	5.36e-06	0.00013	CcSEcCtD
Paclitaxel—Oedema—Docetaxel—lung cancer	5.35e-06	0.00013	CcSEcCtD
Paclitaxel—Anaphylactic shock—Docetaxel—lung cancer	5.35e-06	0.00013	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—lung cancer	5.35e-06	0.000129	CcSEcCtD
Paclitaxel—Pruritus—Gemcitabine—lung cancer	5.34e-06	0.000129	CcSEcCtD
Paclitaxel—Urethral disorder—Methotrexate—lung cancer	5.32e-06	0.000129	CcSEcCtD
Paclitaxel—Infection—Docetaxel—lung cancer	5.32e-06	0.000129	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—lung cancer	5.31e-06	0.000129	CcSEcCtD
Paclitaxel—Feeling abnormal—Etoposide—lung cancer	5.31e-06	0.000128	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—lung cancer	5.3e-06	0.000128	CcSEcCtD
Paclitaxel—Diarrhoea—Irinotecan—lung cancer	5.3e-06	0.000128	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—lung cancer	5.27e-06	0.000128	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Etoposide—lung cancer	5.27e-06	0.000127	CcSEcCtD
Paclitaxel—Shock—Docetaxel—lung cancer	5.27e-06	0.000127	CcSEcCtD
Paclitaxel—Nervous system disorder—Docetaxel—lung cancer	5.25e-06	0.000127	CcSEcCtD
Paclitaxel—Thrombocytopenia—Docetaxel—lung cancer	5.24e-06	0.000127	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—lung cancer	5.24e-06	0.000127	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—lung cancer	5.24e-06	0.000127	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—lung cancer	5.23e-06	0.000127	CcSEcCtD
Paclitaxel—Tachycardia—Docetaxel—lung cancer	5.22e-06	0.000126	CcSEcCtD
Paclitaxel—Skin disorder—Docetaxel—lung cancer	5.2e-06	0.000126	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.19e-06	0.000126	CcSEcCtD
Paclitaxel—Hypersensitivity—Cisplatin—lung cancer	5.18e-06	0.000125	CcSEcCtD
Paclitaxel—Diarrhoea—Gemcitabine—lung cancer	5.16e-06	0.000125	CcSEcCtD
Paclitaxel—Renal failure—Doxorubicin—lung cancer	5.15e-06	0.000125	CcSEcCtD
Paclitaxel—Erythema multiforme—Methotrexate—lung cancer	5.13e-06	0.000124	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—lung cancer	5.13e-06	0.000124	CcSEcCtD
Paclitaxel—Dizziness—Irinotecan—lung cancer	5.12e-06	0.000124	CcSEcCtD
Paclitaxel—Urticaria—Etoposide—lung cancer	5.12e-06	0.000124	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—lung cancer	5.1e-06	0.000124	CcSEcCtD
Paclitaxel—Anorexia—Docetaxel—lung cancer	5.1e-06	0.000124	CcSEcCtD
Paclitaxel—Abdominal pain—Etoposide—lung cancer	5.09e-06	0.000123	CcSEcCtD
Paclitaxel—Body temperature increased—Etoposide—lung cancer	5.09e-06	0.000123	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—lung cancer	5.09e-06	0.000123	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—lung cancer	5.09e-06	0.000123	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—lung cancer	5.07e-06	0.000123	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—lung cancer	5.06e-06	0.000123	CcSEcCtD
Paclitaxel—Asthenia—Cisplatin—lung cancer	5.04e-06	0.000122	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—lung cancer	5.04e-06	0.000122	CcSEcCtD
Paclitaxel—Hypotension—Docetaxel—lung cancer	5e-06	0.000121	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—lung cancer	4.99e-06	0.000121	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—lung cancer	4.95e-06	0.00012	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—lung cancer	4.94e-06	0.00012	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—lung cancer	4.93e-06	0.000119	CcSEcCtD
Paclitaxel—Vomiting—Irinotecan—lung cancer	4.92e-06	0.000119	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—lung cancer	4.91e-06	0.000119	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—lung cancer	4.9e-06	0.000119	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—lung cancer	4.89e-06	0.000118	CcSEcCtD
Paclitaxel—Rash—Irinotecan—lung cancer	4.88e-06	0.000118	CcSEcCtD
Paclitaxel—Dermatitis—Irinotecan—lung cancer	4.88e-06	0.000118	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Docetaxel—lung cancer	4.88e-06	0.000118	CcSEcCtD
Paclitaxel—Chills—Methotrexate—lung cancer	4.87e-06	0.000118	CcSEcCtD
Paclitaxel—Headache—Irinotecan—lung cancer	4.85e-06	0.000117	CcSEcCtD
Paclitaxel—Insomnia—Docetaxel—lung cancer	4.84e-06	0.000117	CcSEcCtD
Paclitaxel—Diarrhoea—Cisplatin—lung cancer	4.81e-06	0.000116	CcSEcCtD
Paclitaxel—Paraesthesia—Docetaxel—lung cancer	4.81e-06	0.000116	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—lung cancer	4.8e-06	0.000116	CcSEcCtD
Paclitaxel—Vomiting—Gemcitabine—lung cancer	4.8e-06	0.000116	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—lung cancer	4.79e-06	0.000116	CcSEcCtD
Paclitaxel—Dyspnoea—Docetaxel—lung cancer	4.77e-06	0.000116	CcSEcCtD
Paclitaxel—Somnolence—Docetaxel—lung cancer	4.76e-06	0.000115	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—lung cancer	4.76e-06	0.000115	CcSEcCtD
Paclitaxel—Rash—Gemcitabine—lung cancer	4.76e-06	0.000115	CcSEcCtD
Paclitaxel—Dermatitis—Gemcitabine—lung cancer	4.75e-06	0.000115	CcSEcCtD
Paclitaxel—Hypersensitivity—Etoposide—lung cancer	4.74e-06	0.000115	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—lung cancer	4.73e-06	0.000114	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—lung cancer	4.73e-06	0.000114	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—lung cancer	4.73e-06	0.000114	CcSEcCtD
Paclitaxel—Headache—Gemcitabine—lung cancer	4.72e-06	0.000114	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—lung cancer	4.71e-06	0.000114	CcSEcCtD
Paclitaxel—Dyspepsia—Docetaxel—lung cancer	4.71e-06	0.000114	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—lung cancer	4.7e-06	0.000114	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—lung cancer	4.68e-06	0.000113	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—lung cancer	4.67e-06	0.000113	CcSEcCtD
Paclitaxel—Decreased appetite—Docetaxel—lung cancer	4.65e-06	0.000113	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—lung cancer	4.64e-06	0.000112	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—lung cancer	4.63e-06	0.000112	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—lung cancer	4.63e-06	0.000112	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Docetaxel—lung cancer	4.62e-06	0.000112	CcSEcCtD
Paclitaxel—Asthenia—Etoposide—lung cancer	4.62e-06	0.000112	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—lung cancer	4.62e-06	0.000112	CcSEcCtD
Paclitaxel—Fatigue—Docetaxel—lung cancer	4.61e-06	0.000112	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—lung cancer	4.61e-06	0.000112	CcSEcCtD
Paclitaxel—Nausea—Irinotecan—lung cancer	4.6e-06	0.000111	CcSEcCtD
Paclitaxel—Constipation—Docetaxel—lung cancer	4.58e-06	0.000111	CcSEcCtD
Paclitaxel—Pain—Docetaxel—lung cancer	4.58e-06	0.000111	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—lung cancer	4.57e-06	0.000111	CcSEcCtD
Paclitaxel—Pruritus—Etoposide—lung cancer	4.56e-06	0.00011	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—lung cancer	4.53e-06	0.00011	CcSEcCtD
Paclitaxel—Nausea—Gemcitabine—lung cancer	4.48e-06	0.000108	CcSEcCtD
Paclitaxel—Vomiting—Cisplatin—lung cancer	4.47e-06	0.000108	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—lung cancer	4.45e-06	0.000108	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—lung cancer	4.45e-06	0.000108	CcSEcCtD
Paclitaxel—Rash—Cisplatin—lung cancer	4.43e-06	0.000107	CcSEcCtD
Paclitaxel—Dermatitis—Cisplatin—lung cancer	4.43e-06	0.000107	CcSEcCtD
Paclitaxel—Feeling abnormal—Docetaxel—lung cancer	4.41e-06	0.000107	CcSEcCtD
Paclitaxel—Diarrhoea—Etoposide—lung cancer	4.41e-06	0.000107	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—lung cancer	4.39e-06	0.000106	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—lung cancer	4.39e-06	0.000106	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—lung cancer	4.38e-06	0.000106	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Docetaxel—lung cancer	4.38e-06	0.000106	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—lung cancer	4.37e-06	0.000106	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—lung cancer	4.36e-06	0.000106	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—lung cancer	4.36e-06	0.000106	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—lung cancer	4.27e-06	0.000103	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—lung cancer	4.26e-06	0.000103	CcSEcCtD
Paclitaxel—Dizziness—Etoposide—lung cancer	4.26e-06	0.000103	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—lung cancer	4.25e-06	0.000103	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—lung cancer	4.25e-06	0.000103	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—lung cancer	4.24e-06	0.000103	CcSEcCtD
Paclitaxel—Abdominal pain—Docetaxel—lung cancer	4.23e-06	0.000102	CcSEcCtD
Paclitaxel—Body temperature increased—Docetaxel—lung cancer	4.23e-06	0.000102	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—lung cancer	4.23e-06	0.000102	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—lung cancer	4.22e-06	0.000102	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—lung cancer	4.2e-06	0.000102	CcSEcCtD
Paclitaxel—Nausea—Cisplatin—lung cancer	4.18e-06	0.000101	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—lung cancer	4.15e-06	0.000101	CcSEcCtD
Paclitaxel—Cough—Methotrexate—lung cancer	4.12e-06	9.99e-05	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—lung cancer	4.12e-06	9.97e-05	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—lung cancer	4.1e-06	9.91e-05	CcSEcCtD
Paclitaxel—Vomiting—Etoposide—lung cancer	4.09e-06	9.91e-05	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—lung cancer	4.09e-06	9.91e-05	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—lung cancer	4.09e-06	9.91e-05	CcSEcCtD
Paclitaxel—Rash—Etoposide—lung cancer	4.06e-06	9.83e-05	CcSEcCtD
Paclitaxel—Dermatitis—Etoposide—lung cancer	4.06e-06	9.82e-05	CcSEcCtD
Paclitaxel—Headache—Etoposide—lung cancer	4.03e-06	9.77e-05	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—lung cancer	4.03e-06	9.76e-05	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—lung cancer	4.02e-06	9.74e-05	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—lung cancer	4.02e-06	9.74e-05	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—lung cancer	4.02e-06	9.74e-05	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—lung cancer	4.02e-06	9.72e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—lung cancer	4.01e-06	9.7e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4e-06	9.67e-05	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—lung cancer	3.98e-06	9.63e-05	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—lung cancer	3.98e-06	9.62e-05	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—lung cancer	3.96e-06	9.58e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Docetaxel—lung cancer	3.94e-06	9.55e-05	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—lung cancer	3.93e-06	9.53e-05	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—lung cancer	3.89e-06	9.42e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—lung cancer	3.86e-06	9.34e-05	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—lung cancer	3.86e-06	9.34e-05	CcSEcCtD
Paclitaxel—Asthenia—Docetaxel—lung cancer	3.84e-06	9.3e-05	CcSEcCtD
Paclitaxel—Infection—Methotrexate—lung cancer	3.83e-06	9.28e-05	CcSEcCtD
Paclitaxel—Nausea—Etoposide—lung cancer	3.83e-06	9.26e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—lung cancer	3.8e-06	9.19e-05	CcSEcCtD
Paclitaxel—Pruritus—Docetaxel—lung cancer	3.79e-06	9.17e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—lung cancer	3.78e-06	9.16e-05	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—lung cancer	3.78e-06	9.16e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—lung cancer	3.78e-06	9.14e-05	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—lung cancer	3.76e-06	9.11e-05	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—lung cancer	3.75e-06	9.07e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—lung cancer	3.73e-06	9.03e-05	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—lung cancer	3.69e-06	8.94e-05	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—lung cancer	3.68e-06	8.9e-05	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—lung cancer	3.68e-06	8.9e-05	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—lung cancer	3.67e-06	8.89e-05	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—lung cancer	3.66e-06	8.87e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Docetaxel—lung cancer	3.66e-06	8.87e-05	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—lung cancer	3.62e-06	8.76e-05	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—lung cancer	3.6e-06	8.73e-05	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—lung cancer	3.6e-06	8.71e-05	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—lung cancer	3.57e-06	8.65e-05	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—lung cancer	3.55e-06	8.58e-05	CcSEcCtD
Paclitaxel—Dizziness—Docetaxel—lung cancer	3.54e-06	8.57e-05	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—lung cancer	3.53e-06	8.55e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—lung cancer	3.51e-06	8.51e-05	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—lung cancer	3.49e-06	8.45e-05	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—lung cancer	3.48e-06	8.44e-05	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—lung cancer	3.48e-06	8.44e-05	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—lung cancer	3.48e-06	8.44e-05	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—lung cancer	3.47e-06	8.41e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—lung cancer	3.46e-06	8.39e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.46e-06	8.38e-05	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—lung cancer	3.44e-06	8.33e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—lung cancer	3.44e-06	8.33e-05	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—lung cancer	3.43e-06	8.3e-05	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—lung cancer	3.41e-06	8.25e-05	CcSEcCtD
Paclitaxel—Vomiting—Docetaxel—lung cancer	3.4e-06	8.24e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—lung cancer	3.4e-06	8.22e-05	CcSEcCtD
Paclitaxel—Rash—Docetaxel—lung cancer	3.37e-06	8.17e-05	CcSEcCtD
Paclitaxel—Dermatitis—Docetaxel—lung cancer	3.37e-06	8.16e-05	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—lung cancer	3.37e-06	8.15e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—lung cancer	3.35e-06	8.12e-05	CcSEcCtD
Paclitaxel—Headache—Docetaxel—lung cancer	3.35e-06	8.12e-05	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—lung cancer	3.34e-06	8.09e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—lung cancer	3.34e-06	8.09e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—lung cancer	3.33e-06	8.06e-05	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—lung cancer	3.33e-06	8.05e-05	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—lung cancer	3.32e-06	8.03e-05	CcSEcCtD
Paclitaxel—Pain—Methotrexate—lung cancer	3.3e-06	7.99e-05	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—lung cancer	3.29e-06	7.96e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—lung cancer	3.28e-06	7.93e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—lung cancer	3.27e-06	7.92e-05	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—lung cancer	3.26e-06	7.89e-05	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—lung cancer	3.24e-06	7.85e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—lung cancer	3.23e-06	7.82e-05	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—lung cancer	3.18e-06	7.71e-05	CcSEcCtD
Paclitaxel—Nausea—Docetaxel—lung cancer	3.18e-06	7.7e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—lung cancer	3.18e-06	7.7e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—lung cancer	3.15e-06	7.64e-05	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—lung cancer	3.12e-06	7.56e-05	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—lung cancer	3.06e-06	7.42e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—lung cancer	3.05e-06	7.38e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—lung cancer	3.05e-06	7.38e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.04e-06	7.37e-05	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—lung cancer	3.02e-06	7.31e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—lung cancer	3e-06	7.26e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—lung cancer	2.98e-06	7.21e-05	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—lung cancer	2.97e-06	7.19e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—lung cancer	2.94e-06	7.12e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—lung cancer	2.9e-06	7.03e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—lung cancer	2.88e-06	6.98e-05	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—lung cancer	2.88e-06	6.97e-05	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—lung cancer	2.86e-06	6.92e-05	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—lung cancer	2.86e-06	6.92e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—lung cancer	2.84e-06	6.88e-05	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—lung cancer	2.77e-06	6.7e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—lung cancer	2.75e-06	6.66e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—lung cancer	2.73e-06	6.61e-05	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—lung cancer	2.73e-06	6.61e-05	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—lung cancer	2.65e-06	6.42e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—lung cancer	2.64e-06	6.39e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—lung cancer	2.64e-06	6.39e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—lung cancer	2.64e-06	6.39e-05	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—lung cancer	2.55e-06	6.18e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—lung cancer	2.46e-06	5.96e-05	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—lung cancer	2.45e-06	5.94e-05	CcSEcCtD
Paclitaxel—Rash—Methotrexate—lung cancer	2.43e-06	5.89e-05	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—lung cancer	2.43e-06	5.88e-05	CcSEcCtD
Paclitaxel—Headache—Methotrexate—lung cancer	2.42e-06	5.85e-05	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—lung cancer	2.4e-06	5.8e-05	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—lung cancer	2.36e-06	5.72e-05	CcSEcCtD
Paclitaxel—Nausea—Methotrexate—lung cancer	2.29e-06	5.55e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—lung cancer	2.29e-06	5.53e-05	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—lung cancer	2.21e-06	5.35e-05	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—lung cancer	2.12e-06	5.14e-05	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—lung cancer	2.11e-06	5.1e-05	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—lung cancer	2.1e-06	5.09e-05	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—lung cancer	2.09e-06	5.07e-05	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—lung cancer	1.98e-06	4.8e-05	CcSEcCtD
Paclitaxel—ABCB1—Metabolism—GSTT1—lung cancer	6.09e-07	2.54e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CG—lung cancer	6.08e-07	2.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CG—lung cancer	6.05e-07	2.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—STK11—lung cancer	6.04e-07	2.53e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	6.04e-07	2.52e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GCLC—lung cancer	6.02e-07	2.51e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP2A6—lung cancer	6.02e-07	2.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCG2—lung cancer	5.98e-07	2.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ADCY1—lung cancer	5.98e-07	2.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.91e-07	2.47e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP2E1—lung cancer	5.87e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HPGDS—lung cancer	5.86e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO2—lung cancer	5.86e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CG—lung cancer	5.85e-07	2.45e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—APOA1—lung cancer	5.83e-07	2.44e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—lung cancer	5.83e-07	2.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPP2R1B—lung cancer	5.82e-07	2.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NQO1—lung cancer	5.81e-07	2.43e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—POMC—lung cancer	5.78e-07	2.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—APOA1—lung cancer	5.78e-07	2.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—POMC—lung cancer	5.76e-07	2.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	5.75e-07	2.4e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ENO1—lung cancer	5.7e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.7e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MDM2—lung cancer	5.69e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—RRM1—lung cancer	5.69e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA3—lung cancer	5.69e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTT1—lung cancer	5.68e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.68e-07	2.38e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—RAF1—lung cancer	5.67e-07	2.37e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—lung cancer	5.67e-07	2.37e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CREBBP—lung cancer	5.63e-07	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.63e-07	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2A6—lung cancer	5.62e-07	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GCLC—lung cancer	5.62e-07	2.35e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CREBBP—lung cancer	5.61e-07	2.34e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—lung cancer	5.61e-07	2.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	5.6e-07	2.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTP1—lung cancer	5.59e-07	2.34e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—POMC—lung cancer	5.57e-07	2.33e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTOR—lung cancer	5.54e-07	2.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CB—lung cancer	5.54e-07	2.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CD4—lung cancer	5.53e-07	2.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—lung cancer	5.48e-07	2.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAT—lung cancer	5.44e-07	2.27e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CREBBP—lung cancer	5.43e-07	2.27e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—EP300—lung cancer	5.4e-07	2.26e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—lung cancer	5.39e-07	2.25e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—B4GALT5—lung cancer	5.35e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—lung cancer	5.34e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	5.33e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—lung cancer	5.33e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO1—lung cancer	5.33e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—lung cancer	5.32e-07	2.23e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—lung cancer	5.32e-07	2.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	5.31e-07	2.22e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—lung cancer	5.29e-07	2.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—lung cancer	5.28e-07	2.21e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—lung cancer	5.27e-07	2.2e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—lung cancer	5.25e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	5.24e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—STK11—lung cancer	5.23e-07	2.19e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA4—lung cancer	5.2e-07	2.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TYMS—lung cancer	5.2e-07	2.17e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—lung cancer	5.16e-07	2.16e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—lung cancer	5.14e-07	2.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTM1—lung cancer	5.14e-07	2.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP2E1—lung cancer	5.11e-07	2.14e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—EP300—lung cancer	5.09e-07	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—lung cancer	5.08e-07	2.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA2—lung cancer	5.07e-07	2.12e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—POMC—lung cancer	5.07e-07	2.12e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NQO1—lung cancer	5.06e-07	2.11e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—POMC—lung cancer	5.02e-07	2.1e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CREBBP—lung cancer	4.94e-07	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.91e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CREBBP—lung cancer	4.89e-07	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA1—lung cancer	4.89e-07	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1A1—lung cancer	4.87e-07	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—lung cancer	4.84e-07	2.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCC3—lung cancer	4.84e-07	2.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ERCC2—lung cancer	4.83e-07	2.02e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.82e-07	2.02e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—lung cancer	4.79e-07	2e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—lung cancer	4.78e-07	2e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2E1—lung cancer	4.78e-07	2e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—lung cancer	4.76e-07	1.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NQO1—lung cancer	4.72e-07	1.97e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAT—lung cancer	4.71e-07	1.97e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.68e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1C1—lung cancer	4.68e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—lung cancer	4.68e-07	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—lung cancer	4.66e-07	1.95e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—lung cancer	4.64e-07	1.94e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—lung cancer	4.64e-07	1.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.63e-07	1.93e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—lung cancer	4.62e-07	1.93e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—lung cancer	4.61e-07	1.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—lung cancer	4.59e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.58e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—lung cancer	4.58e-07	1.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—lung cancer	4.58e-07	1.91e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EP300—lung cancer	4.56e-07	1.91e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—STK11—lung cancer	4.56e-07	1.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—UGT1A1—lung cancer	4.55e-07	1.9e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TYMS—lung cancer	4.5e-07	1.88e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—lung cancer	4.48e-07	1.87e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTM1—lung cancer	4.45e-07	1.86e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—lung cancer	4.44e-07	1.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SRC—lung cancer	4.44e-07	1.85e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNG11—lung cancer	4.38e-07	1.83e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—lung cancer	4.28e-07	1.79e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—lung cancer	4.27e-07	1.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—STK11—lung cancer	4.26e-07	1.78e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—lung cancer	4.22e-07	1.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1A1—lung cancer	4.22e-07	1.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ERCC2—lung cancer	4.18e-07	1.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—APOA1—lung cancer	4.18e-07	1.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALDOA—lung cancer	4.17e-07	1.74e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAT—lung cancer	4.1e-07	1.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—lung cancer	4.09e-07	1.71e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—lung cancer	4.08e-07	1.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOA3—lung cancer	4.05e-07	1.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—lung cancer	4.04e-07	1.69e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—lung cancer	4.04e-07	1.69e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—lung cancer	4.02e-07	1.68e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—lung cancer	4.01e-07	1.67e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—lung cancer	4.01e-07	1.67e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4e-07	1.67e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—lung cancer	4e-07	1.67e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—lung cancer	3.98e-07	1.66e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ADCY1—lung cancer	3.94e-07	1.65e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCG2—lung cancer	3.94e-07	1.65e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—lung cancer	3.94e-07	1.65e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TYMS—lung cancer	3.92e-07	1.64e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—lung cancer	3.89e-07	1.63e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTM1—lung cancer	3.88e-07	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—lung cancer	3.87e-07	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HPGDS—lung cancer	3.87e-07	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO2—lung cancer	3.87e-07	1.62e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.84e-07	1.61e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—EP300—lung cancer	3.84e-07	1.6e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAT—lung cancer	3.83e-07	1.6e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—EP300—lung cancer	3.82e-07	1.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—lung cancer	3.81e-07	1.59e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.81e-07	1.59e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—lung cancer	3.76e-07	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTT1—lung cancer	3.75e-07	1.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—lung cancer	3.73e-07	1.56e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GCLC—lung cancer	3.71e-07	1.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2A6—lung cancer	3.71e-07	1.55e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—EP300—lung cancer	3.69e-07	1.54e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1A1—lung cancer	3.67e-07	1.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—lung cancer	3.67e-07	1.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TYMS—lung cancer	3.66e-07	1.53e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ERCC2—lung cancer	3.64e-07	1.52e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—POMC—lung cancer	3.63e-07	1.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTM1—lung cancer	3.62e-07	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—APOA1—lung cancer	3.62e-07	1.51e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CREBBP—lung cancer	3.54e-07	1.48e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—lung cancer	3.52e-07	1.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO1—lung cancer	3.51e-07	1.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—lung cancer	3.49e-07	1.46e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.47e-07	1.45e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1A1—lung cancer	3.43e-07	1.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ERCC2—lung cancer	3.4e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—lung cancer	3.37e-07	1.41e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—EP300—lung cancer	3.36e-07	1.41e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—lung cancer	3.35e-07	1.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—EP300—lung cancer	3.33e-07	1.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—lung cancer	3.31e-07	1.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—lung cancer	3.3e-07	1.38e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—lung cancer	3.27e-07	1.36e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—APOA1—lung cancer	3.15e-07	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2E1—lung cancer	3.15e-07	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—POMC—lung cancer	3.14e-07	1.31e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—lung cancer	3.12e-07	1.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NQO1—lung cancer	3.12e-07	1.3e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—lung cancer	3.07e-07	1.28e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CREBBP—lung cancer	3.06e-07	1.28e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—lung cancer	2.99e-07	1.25e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—APOA1—lung cancer	2.95e-07	1.23e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—lung cancer	2.92e-07	1.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—lung cancer	2.9e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—lung cancer	2.9e-07	1.21e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—lung cancer	2.88e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—lung cancer	2.87e-07	1.2e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—lung cancer	2.84e-07	1.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—lung cancer	2.83e-07	1.18e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.82e-07	1.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—STK11—lung cancer	2.81e-07	1.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—lung cancer	2.76e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—POMC—lung cancer	2.74e-07	1.15e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—lung cancer	2.73e-07	1.14e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—lung cancer	2.69e-07	1.12e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CREBBP—lung cancer	2.67e-07	1.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—lung cancer	2.6e-07	1.09e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—POMC—lung cancer	2.56e-07	1.07e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—lung cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—lung cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAT—lung cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—lung cancer	2.53e-07	1.06e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—lung cancer	2.51e-07	1.05e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—lung cancer	2.5e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CREBBP—lung cancer	2.49e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—lung cancer	2.49e-07	1.04e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—lung cancer	2.46e-07	1.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—lung cancer	2.46e-07	1.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TYMS—lung cancer	2.42e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—EP300—lung cancer	2.41e-07	1.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTM1—lung cancer	2.39e-07	9.98e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—lung cancer	2.36e-07	9.88e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—lung cancer	2.33e-07	9.75e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—lung cancer	2.32e-07	9.69e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—lung cancer	2.31e-07	9.65e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1A1—lung cancer	2.26e-07	9.46e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ERCC2—lung cancer	2.25e-07	9.39e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—lung cancer	2.23e-07	9.33e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—lung cancer	2.21e-07	9.22e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—lung cancer	2.19e-07	9.14e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—lung cancer	2.19e-07	9.13e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—EP300—lung cancer	2.09e-07	8.72e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—lung cancer	2.06e-07	8.61e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—lung cancer	2.04e-07	8.53e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—lung cancer	2.03e-07	8.49e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—lung cancer	2.01e-07	8.42e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—APOA1—lung cancer	1.94e-07	8.12e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—lung cancer	1.91e-07	7.97e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—EP300—lung cancer	1.82e-07	7.6e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—lung cancer	1.78e-07	7.45e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—lung cancer	1.78e-07	7.44e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—lung cancer	1.77e-07	7.41e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—EP300—lung cancer	1.7e-07	7.1e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—POMC—lung cancer	1.69e-07	7.06e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CREBBP—lung cancer	1.64e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—lung cancer	1.56e-07	6.52e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—lung cancer	1.54e-07	6.45e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—lung cancer	1.54e-07	6.43e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—lung cancer	1.46e-07	6.08e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—lung cancer	1.36e-07	5.68e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—lung cancer	1.35e-07	5.63e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—lung cancer	1.34e-07	5.62e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—lung cancer	1.26e-07	5.27e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—lung cancer	1.26e-07	5.25e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—lung cancer	1.17e-07	4.91e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—EP300—lung cancer	1.12e-07	4.68e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—lung cancer	1.1e-07	4.59e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—lung cancer	1.03e-07	4.29e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—lung cancer	8.28e-08	3.46e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—lung cancer	6.77e-08	2.83e-06	CbGpPWpGaD
